Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Cognitive Remediation Intervention to Prepare for Transition of Care [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a cognitive remediation intervention to prepare adolescents with sickle cell disease and cognitive impairment for transition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Sickle Cell Disease, Cognitive Impairment | Phase 2 | Status: RECRUITING